Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations.

Allison Lipitz-SnydermanSusan ChimonasSham MailankodyMichelle KimNicholas SilvaAnuja KriplaniLeonard B SaltzSmita SihagCarlyn Rose TanMaria WidmarMarjorie ZaudererSaul N WeingartWendy PerchickBenjamin R Roman

Published in: Cancer medicine (2023)

Second-opinion consultations sometimes add clinical value by improving expected prognoses; more often, they offer treatment de-escalations, with corresponding reductions in expected short- and/or long-term morbidity. Future research could identify subgroups of patients most likely to benefit from second opinions.

Keyphrases

end stage renal disease
chronic kidney disease
palliative care
prognostic factors
peritoneal dialysis
patient reported outcomes
primary care
current status
patient reported